ClarityVesting

Sign in Get free access

Healthcare

Stock Analysis · Thermo Fisher Scientific Inc (TMO)

Thermo Fisher supplies the tools, instruments, diagnostics, and manufacturing services behind modern drug research and lab testing. Scale, strong margins, and resilient cash flow keep it near the top of the life sciences field as growth improves again.

Stock Analysis · Pfizer Inc (PFE)

Pfizer is a global drugmaker reshaping itself after the pandemic boom. Its scale, cash generation, dividend support, and larger oncology platform through Seagen stand out, while the next phase depends on turning pipeline depth and new launches into steadier growth.

Stock Analysis · Novartis AG (NVS)

Novartis is a focused global drug maker built around patented medicines in heart disease, cancer, immunology, and neuroscience. Strong margins, rising cash flow, and several newer growth products make its long-term business profile especially worth a closer look.

Stock Analysis · Merck & Company Inc (MRK)

Merck is a global drugmaker built around a powerful oncology franchise, vaccines, and animal health. Strong cash generation and a growing pipeline support the outlook, while new products such as Winrevair are central to how the company plans its next phase.

Stock Analysis · Eli Lilly and Company (LLY)

Eli Lilly is a global drugmaker whose recent surge has been powered by Mounjaro and Zepbound. Rapid growth, elite margins, and a deep pipeline in obesity, diabetes, and neuroscience make it one of healthcare’s most closely watched long-term compounders.

Stock Analysis · Medtronic PLC (MDT)

Medtronic is a global medical device leader spanning heart care, surgery, neuroscience, and diabetes. Strong margins, large cash generation, and improving revenue momentum make its cardiovascular pipeline and hospital technology upgrades especially worth a closer look.

Stock Analysis · Intuitive Surgical Inc (ISRG)

Intuitive Surgical makes robotic surgical systems and earns most of its revenue from recurring instruments, accessories, and service. Strong procedure growth, high margins, major cash generation, and category leadership make it a standout business worth deeper analysis.